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Background: Probiotic bacteria are increasingly used as immunomodulatory agents. Yet detailed molecular
knowledge on the immunomodulatory molecules of these bacteria is lagging behind. Lipoteichoic acid (LTA) is
considered a major microbe-associated molecular pattern (MAMP) of Gram-positive bacteria. However, many details
and quantitative data on its immune signalling capacity are still unknown, especially in beneficial bacteria. Recently,
we have demonstrated that a dltD mutant of the model probiotic Lactobacillus rhamnosus GG (LGG), having
modified LTA molecules, has an enhanced probiotic efficacy in a DSS-induced colitis model as compared to
wild-type.
Results: In this study, the importance of D-alanylated and acylated LTA for the pro-inflammatory activity of LGG
was studied in vitro. Purified native LTA of LGG wild-type exhibited a concentration-dependent activation of NF-κB
signalling in HEK293T cells after interaction with TLR2/6, but not with TLR2 alone. Chemical deacylation of LTA
interfered with the TLR2/6 interaction, while a moderate effect was observed with chemical dealanylation. Similarly,
the dltD mutant of LGG exhibited a significantly reduced capacity to activate TLR2/6-dependent NF-κB signalling in
a HEK293T reporter cell line compared to wild-type. In addition, the dltD mutant of LGG showed a reduced
induction of mRNA of the chemokine IL-8 in the Caco-2 epithelial cell line compared to wild-type. Experiments with
highly purified LTA of LGG confirmed that LTA is a crucial factor for IL-8 mRNA induction in Caco-2 epithelial cells.
Chemical dealanylation and deacylation reduced IL-8 mRNA expression.
Conclusions: Taken together, our results indicate that LTA of LGG is a crucial MAMP with pro-inflammatory
activities such as IL-8 induction in intestinal epithelial cells and NF-κB induction in HEK293T cells via TLR2/6
interaction. The lipid chains of LGG LTA are needed for these activities, while also the D-alanine substituents are
important, especially for IL-8 induction in Caco-2 cells.
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The immunomodulatory potential of probiotic bacteria
is of increasing interest for prophylactic and therapeutic
options in various complex disorders, ranging from diar-
rhea to allergy. However, clinical and intervention stu-
dies with probiotics are not universally effective. For* Correspondence: sarah.lebeer@biw.kuleuven.be
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reproduction in any medium, provided the orinstance, the well-known probiotic Lactobacillus rham-
nosus GG (LGG) shows promising results in the preven-
tion of atopic disease [1-3], prevention and relief of
diarrhea [4] and prevention of respiratory tract infec-
tions in children [5], while the results in Crohn’s disease
are less promising [6-8]. Clearly, the mode and timing of
delivery and severity of the conditions are important fac-
tors in determining probiotic efficacy. To select the opti-
mal strain for each application, detailed molecular
knowledge would be of great help. Many immunomodu-
latory molecules of bacteria are microbe-associatedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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pattern recognition receptors (PRRs) such as Toll-like
receptors (TLRs). PRRs expressed on host cells such as
intestinal epithelial cells (IECs) and dendritic cells (DCs)
in the gastro-intestinal tract appear to be especially
crucial for probiotic-host interactions. The interaction
between a MAMP and a PRR on host cells results in
the induction of signalling cascades that mount a mo-
lecular response. This response can include the pro-
duction of pro- or anti-inflammatory cytokines and
chemokines, antimicrobial molecules and cytoprotective
factors [9].
Many MAMPs are surface located molecules, such as
lipopolysaccharides interacting with TLR4/MD2 and fla-
gellin interacting with TLR5. Lipoteichoic acid (LTA) is a
widely studied MAMP of the low G+C subdivision of the
Gram-positive bacteria such as the Firmicutes. LTA is an
amphiphilic molecule of which the hydrophilic region is
generally composed of a 1,3-phosphodiester-linked poly-
mer of glycerol-phosphate or ribitol-phosphate variously
substituted with D-alanine or sugars. The hydrophobic
region is a glycolipid, often Glc(β1-6)Glc(β1-3)diacylgly-
cerol [10]. LTA of several pathogens such as Staphylococ-
cus aureus, Streptococcus pyogenes and Streptococcus
pneumoniae has been shown to trigger the production of
pro-inflammatory cytokines, nitric oxide (NO) and other
pro-inflammatory mediators in various cell types [10,11].
Similar to LPS, LTA appears to be an important endo-
toxin capable of causing sepsis. However, whereas LPS is
active in the nanomolar range, biological activities of
LTA are mostly observed in the micromolar range [11].
Moreover, the activity of LTA is often debated due to
problems with contaminants such as lipoproteins and
loss of bio-active residues during isolation and purifica-
tion [12]. Some studies have indicated that TLR2 is an
important PRR for pathogenic LTA of Streptococcus
pneumoniae [13] and Staphylococcus aureus [14], but
generally without detailed mechanistic insights.
Recently, LTA molecules of probiotic lactobacilli have
gained interest as important immune modulators based
on studies with LTA mutants showing enhanced efficacy
in experimental colitis models [15]. We observed pre-
viously that LGG wild-type can aggravate colitic symp-
toms in a DSS-induced colitis model in mice, suggesting
that pro-inflammatory molecules of LGG itself can trig-
ger an enhanced inflammatory response in certain con-
ditions such as in severely progressed colitis [16]. In
contrast to LGG wild-type, adding the dltD mutant of
LGG seemed to improve colitic symptoms compared to
the PBS control. This dltD mutant was previously shown
to lack D-Ala on its LTA, but also expresses a modified
glycolipid anchor and a shorter polyglycerol-P chain
[17]. Similarly, a dlt mutant with modified D-alanylation
of LTA was shown to have a higher anti-inflammatorypotential in L. plantarum NCIMB8826 [18], while LTA
removal in L. acidophilus NCFM conferred improved
anti-inflammatory properties in several mouse models
for IBD [19]. However, only very limited data exist on
the structure-activity relationship of LTA of probiotic
lactobacilli. In this study, we aimed to provide molecular
insights in the biological activity of LTA of the widely
used and model probiotic strain LGG, by investigating
its potential pro-inflammatory activity and its interaction
with PRRs in cell models.
Results
Isolation and chemical characterization of native and
modified LTA of LGG
Highly purified LTA of LGG was isolated as described in
Methods. In order to verify its structure, purified LTA
was analysed with 1H-NMR. Hereto, 5 mg of purified
LTA was dissolved in D2O. The obtained spectra were
compared to 1H-NMR-spectra described in literature
and showed to have > 99% purity (Figure 1).
The molecular structure determined by 1H-NMR
spectroscopy confirmed that isolated LTA from LGG
wild-type cells consists of a glycerolphosphate backbone
decorated with D-alanyl esters as unique detectable sub-
stituents. The D-alanine content was calculated based
on the integral ratios to be 71.8% (see structural repre-
sentation in Figure 2 based on NMR spectra in
Figure 1A). The chain length (n) of the glycerophosphate
residues in LTA from LGG wild-type in the LTA sample
analysed was around 30, based on the 1H NMR integrals
of native LTA (Figure 1A). Some variation was noted be-
tween different biological samples with values ranging
between n = 30 and n = 76 (a representative LTA sample
is shown in Figure 1). Analysis of the glycolipid moiety
reveals an average fatty acid chain of C14, with one
double bond per fatty acid (two double bonds in every
membrane anchor). The position of this double bond
cannot be verified from these spectra and is therefore ar-
bitrarily represented in Figure 2. LTA was also isolated
from the dltD mutant of LGG, but NMR analysis
showed too much impurities for detailed studies. As an
alternative, purified LTA from LGG wild-type was che-
mically deacylated and dealanylated for determination of
the structure-activity relationships by two different treat-
ments (moderate and harsh alkaline hydrolysis) based on
[20] and structural changes were confirmed by NMR. A
moderate alkaline hydrolysis in Tris buffer pH 8.5 for 24
h at 25°C resulted in a drastic reduction of D-Ala ester
substitutions. More specifically, a 71.8% to 15.6% reduc-
tion in the degree of substitution was noticed, based on
the integration ratios of chemical shifts (δ)H 5.35 ppm,
4.25 ppm and 1.65 ppm (see Figure 1B). Only a minor
effect on the acyl chains of the LTA was observed.




















* Gro-2-CH (R = OH, unsubst.) + Gro-1,3-CH2 (R = D-Ala)
A
Figure 1 NMR spectra of native and chemically modified lipoteichoic acid (LTA) of LGG. A) 1H-NMR spectrum (600 MHz) of a
representative sample of purified LTA from LGG wild type. B) 1H-NMR spectrum of purified LTA chemically treated to mainly remove D-alanine
esters by alkaline hydrolysis in Tris buffer in D2O pH 8.5 for 24 h at 25°C. C)
1H-NMR spectrum of purified LTA treated by alkaline hydrolysis in
0.1M NaOH for 2 h at 37°C for chemical deacylation. Signals at 3.67 ppm (in B) and 3.56 ppm (in C) are due to the Tris buffer.
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minal CH3 - in Figures 1A and B). The harsh alkaline
hydrolysis treatment with 0.1M NaOH for 2 h at 37°C
significantly reduced the acyl chains (from 100% to 45%)
































Figure 2 Schematic representation of the structure of native LTA from
1H-NMR spectra were analysed and integrated with Topspin 2.0 software. B
the chain length (n) of the polyglycerolphosphate backbone was estimated
were tested). The second carbon of every glycerol was substituted with X,
each have one double bound (of which the exact position was not determ
and confirmed by integration data from this study). For the biological LTA
D-Ala. For mLTA1, X = 15.6% D-Ala, while X = 0% for mLTA2. For mLTA2, 5remaining part of the manuscript, these chemically
modified LTAs will be termed as mLTA1 (isolated LTA
treated by mild alkaline hydrolysis, which results in par-
tial removal of D-Ala) and mLTA2 (isolated LTA treated




LGG wild-type determined by NMR spectroscopy analysis.
ased on the integrations of the corresponding signals in the spectra,
between 30 and 78 depending on a biological variability (4 samples
being either a hydroxyl group or D-alanine. The two acyl chains of LTA
ined) and have a total length of approximately n=14 (based on [17]
sample of LGG wild-type (see also Figure 1), N = 30, while X = 71.8%
5% of the acyl chains of LTA were found to be removed.
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removal) respectively.NF-κB activation of LGG LTA by interaction with TLR2/6
Since LTA of several bacteria, such as Staphylococcus
aureus and L. plantarum, has been demonstrated to be a
ligand for TLR2 [14,18], we first aimed to investigate the
importance of this PRR for the signalling capacity of
LTA of LGG. Hereto, we used HEK293T cells transiently
expressing TLR2 and containing a NF-κB reporter plas-
mid. Surprisingly, expression of only TLR2 on the sur-
face of the HEK293T cells was insufficient to mediate
NF-κB activation by LTA of LGG (Figure 3).
In contrast, transfecting the HEK293T cells with the
vector pDUO-hTLR6/TLR2 (Invivogen), resulting in ex-
pression of both TLR2 and TLR6, did significantly result
in activation of the NF-κB reporter plasmid by 10 μg/ml
LTA of LGG (Figure 4). Lower concentrations of 0.1 and
1 μg/ml did not induce secreted alkaline phosphatase
(SEAP) above baseline levels, which is in line with the
literature [21].Importance of D-Ala substituents and acyl chains for
TLR2/6 interaction by LGG LTA
To establish a structure-activity relation of LTA of LGG
in interaction with TLR2/6 as PRRs, experiments were
performed with chemically deacylated and dealanylated
LTA, i.e. mLTA1 and mLTA2 described above. Partially
modified mLTA1 showed a similar signalling through












TLR2 (-) Pam2CSK4 LTA
Figure 3 TLR2 mediated signalling using HEK293T cells.
HEK293T cells were transfected with pUNO-hTLR2 (Invivogen) alone
(TLR2 (−)) or together with the reporter plasmid pNiFty2-SEAP
(Invivogen). Cells were transiently transfected with the
corresponding plasmids as described in Material & Methods. 24h
after transfection, cells were incubated with Pam2CSK4 (50 ng/ml)
and LTA (10 μg/ml) for 24 hours. After incubation, NF-κB-induced
SEAP activity was assessed using pNPP (p-nitrophynyl phosphate)
and measuring the OD at 405nm. Data represent mean values ± SD.
*p-value < 0.05 compared to the negative control (TLR2(−)).deacetylated and fully dealanylated mLTA2 proved inef-
fective in activating NF-κB (Figure 4).
Interestingly, a similar trend was observed when inves-
tigating the interaction capacity of whole UV-irradiated
bacterial cells. While LGG wild-type was able to signifi-
cantly activate NF-κB signalling via TLR2/6 interaction,
the dltD mutant, having modified LTA [17], significantly
induced less NF-κB (Figure 4).
IL-8 mRNA induction in intestinal epithelial cells by LGG
LTA
Subsequently, we investigated the structure-activity rela-
tionship of LGG LTA in intestinal epithelial cells. Native
LTA of LGG was previously shown to induce IL-8
mRNA in Caco-2 epithelial cells with a maximum acti-
vity around 10 μg/ml [22]. To investigate the role of the
D-Ala substituents and the lipid part of LTA, mLTA1
and mLTA2 were used as described above. Both treat-
ments resulted in a significant reduction in IL-8 mRNA
induction, highlighting the importance of both the acyl
groups and the D-Ala ester substituents of LTA for this
activity (Figure 5A).
In addition, we investigated the IL-8 mRNA induction
capacity of LGG wild-type versus the dltD mutant. Com-
pared to the negative control (DMEM), LGG wild-type
significantly induced IL-8 mRNA, while the dltD mutant
did not (Figure 5B). Blocking experiments with anti-
LTR2 antibodies confirmed the importance of TLR2 for
IL-8 mRNA induction by LGG wild-type (data not
shown).
Discussion
In this study, we aimed to investigate the importance of
the LTA structure of LGG in mediating pro-
inflammatory effects in dedicated cell models. Hereto,
we used highly purified native and chemically modified
LTA of LGG. First, we showed that LGG LTA is able to
activate NF-κB in HEK293T cells via interaction with the
PRR couple TLR2/6. Importantly, this activity was not
observed when the HEK293T cells were only transfected
with TLR2, highlighting the importance of TLR6 as core-
ceptor for LGG LTA. This is in agreement with the PRRs
of LTA molecules of S. aureus and group B streptococci,
which were shown to interact with TLR2/6 and not
TLR1/6 [23]. For lactobacilli, the pro-inflammatory po-
tential of LTA of L. plantarum NCBIM8826 was shown
to be TLR2 dependent using bone marrow cells isolated
from TLR2+/+ and TLR2−/− mice [18]. Experiments with
LTA from L. casei and L. fermentum using HEK293T
cells revealed that CD14 could only activate NF-κB when
cotransfected with TLR2. Taken together, it seems that
the pro-inflammatory character of LTA from different
species is TLR2 dependent but needs coreceptors, such




















TLR2/6 (-) Pam2CSK4 LTA 0.1 LTA 1 LTA 10 mLTA1 mLTA2 LGG dltD
Figure 4 TLR2/6 mediated signalling using HEK293T cells. HEK293T cells were transfected with pDUO-hTLR6/TLR2 (Invivogen) alone
(TLR2/6 (−)) or together with the reporter plasmid pNiFty2-SEAP (Invivogen). Cells were transiently transfected with the respective plasmids as
described in Methods. 24h after transfection, cells were incubated with Pam2CSK4 (50 ng/ml), LTA at 0.1, 1 and 10 μg/ml, mLTA1 (10 μg/ml),
mLTA2 (10 μg/ml), LGG wild-type or dltD mutant cells (108 CFU/ml) for 24 hours. After incubation, NF-κB-induced SEAP activity was assessed
using pNPP (p-nitrophynyl phosphate) and measuring the OD at 405nm. Data represent mean values ± SD. *p-value < 0.05 compared to the
negative control (TLR2/6(−)).
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ically modified LTA confirmed by NMR spectroscopy,
i.e. mLTA1 (mild alkaline hydrolysis - partial removal
of D-Ala) and mLTA2 (harsh alkaline hydrolysis -
complete removal of D-Ala and partial acyl chain re-
moval), D-alanylation does not appear to be crucial for
TLR2/6 interaction. While a harsh chemical deacyla-
tion of 55% (mLTA2) completely abolished the NF-κB
induction by LGG LTA, a severe chemical dealanyla-
tion of 72% (mLTA1) did not significantly affect this
signalling. Our data confirm the essential role of the
lipid part of LTA, as has been previously shown for
other ligands in interaction with TLR2 [24]. Yet, they




















Figure 5 Interleukin-8 mRNA response of human Caco-2 cells to 1.5 h
LGG LTA, mLTA1 and mLTA2 (10 μg/ml) (panel A) or with live LGG WT or t
a negative control. Bacteria were administered at 107 CFUs per ml. The resu
experiments. Data represent mean values ± SD. *p-value < 0.05 comparedsubstituents in signalling. This highlights the import-
ance of structure-activity data for LTA of different
species.
Subsequent experiments with the Caco-2 intestinal
epithelial cells, a cell line that has been extensively used
as a model for the intestinal barrier [25], indicate that
LTA of LGG can indeed induce an inflammatory re-
sponse, in this case a concentration-dependent increase
in mRNA expression of the chemokine IL-8. Chemical
dealanylation (mLTA1) was sufficient to significantly re-
duce IL-8 mRNA induction. These experiments suggest
that the D-Ala substituents of LGG LTA are more im-
portant for IL-8 mRNA induction in Caco-2 cells than





















stimulation with various compounds. Cells were stimulated with
he dltD mutant strain (panel B) for 1.5 hours. DMEM medium served as
lts shown are representative for at least three independent
to the negative control (DMEM).
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in differentiated Caco-2 epithelial cells requires the
interaction of LGG LTA with TLR2/6 and additional co-
receptors interacting with the D-Ala substituents, which
are not present in the less differentiated HEK293T cells.
Furthermore, we could show in this study that the dltD
mutant of LGG shows a significantly reduced pro-
inflammatory capacity compared to wild-type, as
assessed by TLR2/6-dependent NF-kB induction in
HEK293T cells and IL-8 mRNA induction by Caco-2
cells. This is in agreement with its observed reduced
pro-inflammatory and even enhanced anti-inflammatory
and enhanced epithelial repair activity in vivo [16].
Due to pleiotropic effects of the dltD mutation, we
were unable to isolate LTA from the dltD mutant that
was sufficiently pure for immunomodulation experi-
ments. Therefore, we are currently unable to answer the
question as to whether the specific LTA structure of the
dltD mutant as described in Perea Vélez et al. [17],
results in this reduced pro-inflammatory capacity.
Nevertheless, the data for NMR characterized chemical
dealanylated and deacylated LGG LTA confirm the im-
portance of both structural features for its pro-
inflammatory potential.
In conclusion, we have convincingly shown in this
study that LTA of LGG is an important MAMP of LGG
for interaction with TLR2/6. Moreover, LTA is an im-
portant factor in the induction of pro-inflammatory mar-
kers in the Caco-2 intestinal epithelial cell line. This
activity of LTA needs to be taken into account when
selecting the optimal application for LGG. For example,
in a disease situation like active colitis, extra pro-
inflammatory stimulation by LTA of probiotic bacteria
would be undesirable. Although human application of
genetically modified probiotics such as the dltD mutant
of LGG is not an option, experiments with mutants and
isolated compounds such as shown in this study high-
light the importance of tailored applications. Screening
or searching for probiotic strains with less pro-
inflammatory LTA seems to be important for specific
disease conditions with a general pro-inflammatory pro-
file. On the other hand, for application of probiotic
strains or purified LTA as adjuvants, more immunosti-
mulatory characteristics could be more appropriate.
Methods
Bacterial strains, media and growth conditions
LGG and the dltD mutant (CMPG5540) were grown at
37°C in MRS medium (Difco) or AOAC medium (Difco)
under static conditions.
LTA purification
Overnight LGG wild-type cell cultures were centrifuged
for 30 min (4000 rpm, 4°C) and the white cell pelletswere stored at −80°C. Highly purified LTA was isolated
according to Morath et al. [26]. In order to release LTA
from the peptidoglycan matrix, the cells were disrupted
mechanically by sonication. Hence, a defrosted aliquot of
bacteria (ca. 40 g) was suspended in 80 mL of citrate buf-
fer (0.1 M, pH = 4). The milky solution was placed in an
ice bath and 4 subsequent sonication steps were accom-
plished (duty cycle = 50%, output > 50). To remove the
contaminant lipophilic cell molecules from the LTA
containing buffer solution, an extraction step with n-
butanone was applied as described by Morath et al. [20],
as the classical extraction method with phenol-water at
68°C and subsequent dialysis was previously shown to
partly desintegrate structure of the purified LTA.
The purification of LTA was accomplished by hydro-
phobic interaction chromatography (HIC) on an octyl-
Sepharose CL-4B (GE Healthcare) packed in XK 16/60
column (GE Healthcare) using a linear gradient from
15% to 60% n-propanol in ammonium acetate (0.1 M,
pH = 4.75). Hence, the lyophilized sample was sus-
pended in 35 ml of chromatography start buffer (15% n-
propanol in 0.1 M ammonium acetate, pH = 4.75) and
centrifuged for 1 h (15000 rpm, 4°C). After sterilization
by membrane filtration (0.2 μm), the supernatant was
subjected to HIC.
The LTA containing fractions were identified by their
phosphate content using the phosphomolybdenum test
[27]. Therefore, to 50 μL of each fraction 200 μL of an
acid solution (2 M H2SO4/0.44 M HClO4) was added
and the samples were incubated at 140°C for 2 h. Next,
a reduction solution (ammonium heptamolybdate solu-
tion: ascorbine solution 9:1) was added to each sample.
After 2 h of incubation at 50°C, 200 μL of each sample
was transferred into a microtiter plate. Absorption was
measured at 700 nm. The phosphate content was deter-
mined by comparison to a P standard.
The LTA-containing fractions were collected and lyo-
philized after freezing with liquid N2. The lyophilized
fractions were suspended in ca. 10 mL milli-Q water and
lyophilized once more.
Dealanylation of LTA was achieved by increasing the
pH of the water phase after butanol extraction, and by
stirring at pH ≈ 8.5 with Tris buffer at RT (25°C) for
24 h as described previously [20]. Deacylation of LTA
was performed at 37°C for 2 h with 0.1M NaOH [26].
LPS contamination was assessed with that LAL assay
(<0.1 EU/ml; QCL-1000; Lonza).
LTA structure analysis
Proton (1H) Nuclear magnetic resonance (NMR) spectra
of the LTA samples were measured in 5 mm Norell
tubes on a Bruker Avance II-plus 600 MHz spectrometer
equipped with a TXI-5 probe at 298 K. Spectra were
obtained using D2O as a solvent, with the residual
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processing and integrations were performed in Bruker
Topspin 2.1 and 2.0. The length of the polyglyceropho-
sphate backbone, the percentage of substitution of the
second position of every glycerol with D-alanine, and
the average chain length of the fatty acids in the mem-
brane anchor were calculated using the appropriate inte-
grated signals of the proton NMR spectra.
Immunomodulation assay with Caco-2 cells
Caco-2 cells were purchased from ATCC (Rockville,
MD). Cells were routinely grown in 75-cm2 culture
flasks under conditions of 37°C, 5% CO2, and 90% rela-
tive humidity. Dulbecco modified Eagle medium
(DMEM)/F-12 (GibcoBRL) (1:1) supplemented with 10%
fetal bovine serum (FBS; HyClone) was used as the cul-
ture medium. Cells were passaged every 3 days (at 70 to
80% confluency) at a split ratio of 1 to 7. Epithelial cells
were plated at a density of 104 cells/cm2 in 12-well plates
(Cellstar). Confluency was reached within 3 to 4 days
after seeding, and monolayers were used for the experi-
ments 5–7 days after seeding. Caco-2 cells were incu-
bated with LGG wild type, the dltD mutant (107 CFU/ml)
or LTA (at different concentrations) for 1.5 hours.
Analysis of cytokine mRNA levels by qRT-PCR
To determine cytokine mRNA levels by qRT-PCR, com-
mercially available methodologies for performing total
cellular RNA extraction (High pure RNA isolation kit,
Roche), reverse transcription (SuperScript III first-
strand Synthesis system, Invitrogen) and real-time DNA
amplification (TaqMan Universal PCR Master Mix, Ap-
plied Biosystems) were applied. For real-time quantita-
tive PCR (RT-qPCR) amplification, the StepOnePlus
Real Time PCR system (Applied Biosystems, Lennik,
Belgium) was used. All primers and probes were
designed based on published sequences and chemically
synthesized by Eurogentec (Seraing, Belgium). Purified
plasmid DNA specific for each targeted cytokine gene
served as cDNA plasmid standards and was used to
quantify the respective cytokine in the test samples.
The relative abundance of each mRNA species was
measured by qPCR using 45 amplification cycles, with
each cycle consisting of a denaturation step (94°C for
15 s) and a 1 min combined annealing-extension step
(60°C). qPCR data are presented as a ratio of the
mRNA level for cytokine genes over that of the house-
keeping gene peptidylprolyl isomerase A (PPIA), one of
the most stably expressed genes in Caco-2 cells [28].
Transient transfection of HEK293T cells and measurement
of alkaline phosphatase activity
HEK293T cells (ATCC, Manassas, VA, USA) were cul-
tured in DMEM/F-12 (GibcoBRL) (1:1) supplementedwith 6% fetal bovine serum (FBS; HyClone) and
50μg/mL gentamycin in 5% CO2, 37°C, RH 90%. The
cells (0.5 x 106 cells/mL) were seeded in 12-well plates.
These cells were then transfected with either pNiFty-
SEAP alone or in combination with pUNO1-hTLR2 or
pDUO-hTLR6/TLR2 (Invivogen Inc., San Diego, USA)
using branched polyethylenimine (MW ~ 25.000).
Transfected cells were cultured for 24 h and then
incubated with Pam2CSK4 (positive control from Invi-
vogen), LTA, UV inactivated LGG or the dltD mutant
for an additional 24 h. All experiments were per-
formed at least two times. After incubation, NF-κB-
induced secreted alkaline phosphatase (SEAP) activity
was assessed using pNPP (p-nitrophynyl phosphate) at
1 mg/mL and measuring the OD at 405 nm.
Statistics
Values are presented as mean ± SD. Difference were
evaluated by the unpaired Student’s t test. A value of
p ≤ 0.05 was considered to be significant.
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